<Disease><Name>TYROSINE HYDROXYLASE DEFICIENCY</Name><Synonym>SEGAWA SYNDROME, AUTOSOMAL RECESSIVE; L-DOPA RESPONSIVE DYSTONIA</Synonym><OMIM><Number>605407</Number><URL>http://omim.org/entry/605407</URL></OMIM><Orphanet><Number>101150</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=101150</URL></Orphanet><Protein><Number>tyrosine 3-monooxygenase</Number><URL>http://www.uniprot.org/uniprot/P07101</URL></Protein><ExPASy><Number>1.14.16.2</Number><URL>http://enzyme.expasy.org/EC/1.14.16.2</URL></ExPASy><Gene>11p15.5</Gene><ICD>G24.1</ICD><Summary>rare;autosomal recessive;mutation in the tyrosine hydroxylase gene</Summary><Symptoms><symtomp><id>3982</id><symptom>drooling</symptom><category>HEAD</category></symtomp><symtomp><id>1946</id><symptom>dystonia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1979</id><symptom>feeding difficulties, poor feeding</symptom><category>GASTROINTESTINAL SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1882</id><symptom>growth retardation, poor growth</symptom><category>GENERAL TOPICS | GENERAL TOPICS</category></symtomp><symtomp><id>2631</id><symptom>hypersalivation</symptom><category>GENERAL TOPICS | HEAD</category></symtomp><symtomp><id>3627</id><symptom>hypokinesia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>3826</id><symptom>intellectual disability/intellectual developmental disorder</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1951</id><symptom>irritability</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1953</id><symptom>lethargy, drowsiness, apathy</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1886</id><symptom>microcephaly (&lt;2 SD for age)</symptom><category>HEAD</category></symtomp><symtomp><id>1899</id><symptom>muscular rigidity</symptom><category>MUSCLES</category></symtomp><symtomp><id>1900</id><symptom>myoclonus</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2513</id><symptom>oculogyric crisis</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3311</id><symptom>Parkinsonism</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1773</id><symptom>ptosis (drooping eyelid)</symptom><category>EYES</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>4126</id><symptom>sleep disturbances</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1874</id><symptom>speech development, delayed, abnormal</symptom><category>GENERAL TOPICS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1934</id><symptom>sweating</symptom><category>GENERAL TOPICS | SKIN</category></symtomp><symtomp><id>3315</id><symptom>temperature instability</symptom><category>GENERAL TOPICS | GENERAL TOPICS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1944</id><symptom>tremor or twitching</symptom><category>NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>1624</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>normal/dec</value><min>1.80</min><max>12.70</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1702</id><name>Vanillylmandelic acid (VMA)</name><specimen>urine</specimen><value>normal/dec</value><min>1.00</min><max>3.40</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>2140</id><name>Prolactin</name><specimen>serum</specimen><value>increased</value><min>4.79</min><max>23.30</max><unit>ng/ml</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>669</id><name>Vanillylmandelic acid (VMA)</name><specimen>urine</specimen><value>normal/dec</value><min>3.10</min><max>21.80</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>671</id><name>Vanillylmandelic acid (VMA)</name><specimen>urine</specimen><value>normal/dec</value><min>1.30</min><max>11.50</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>670</id><name>Vanillylmandelic acid (VMA)</name><specimen>urine</specimen><value>normal/dec</value><min>12.00</min><max>26.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>672</id><name>Vanillylmandelic acid (VMA)</name><specimen>urine</specimen><value>normal/dec</value><min>3.00</min><max>13.00</max><unit>mmol/mol creatinine</unit><age>childhood 6-12y</age><method /><comment /></metabolite><metabolite><id>673</id><name>Vanillylmandelic acid (VMA)</name><specimen>urine</specimen><value>normal/dec</value><min>3.00</min><max>16.00</max><unit>mmol/mol creatinine</unit><age>adolescence</age><method /><comment /></metabolite><metabolite><id>1387</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>urine</specimen><value>normal/dec</value><min>0.00</min><max>12.00</max><unit>mmol/mol creatinine</unit><age>childhood 4-6y</age><method /><comment /></metabolite><metabolite><id>910</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>cerebrospinal fluid</specimen><value>normal</value><min>120.00</min><max>500.00</max><unit>nmol/l</unit><age /><method /><comment /></metabolite><metabolite><id>931</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>cerebrospinal fluid</specimen><value>normal</value><min>105.00</min><max>299.00</max><unit>nmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1001</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>urine</specimen><value>normal</value><min>    </min><max>11.50</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1388</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>urine</specimen><value>normal</value><min>0.20</min><max>8.70</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>912</id><name>Dopamine</name><specimen>urine</specimen><value>normal/dec</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>684</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>normal/dec</value><min>3.00</min><max>20.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>685</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>normal/dec</value><min>2.00</min><max>19.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>686</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>normal/dec</value><min>6.00</min><max>42.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>687</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>normal/dec</value><min>1.00</min><max>14.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>688</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>normal/dec</value><min>1.00</min><max>5.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method /><comment /></metabolite><metabolite><id>2022</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>normal/dec</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>911</id><name>Homovanillic acid (HVA)</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>100.00</min><max>900.00</max><unit>nmol/l</unit><age>1m-2years</age><method /><comment /></metabolite><metabolite><id>932</id><name>Homovanillic acid (HVA)</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>211.00</min><max>871.00</max><unit>nmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>906</id><name>Dopamine</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>0.00</min><max>0.00</max><unit /><age>no data</age><method /><comment /></metabolite><metabolite><id>913</id><name>Dopamine</name><specimen>plasma</specimen><value>decreased</value><min>    </min><max>    </max><unit>no data</unit><age>no data</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>7569</id><title>[Segawas syndrome]</title><author>Muranova AV,</author><journal>Zh Nevrol Psikhiatr Im S S Korsakova</journal><year>2019</year><book /><volume>119</volume><number>4</number><pages>55-59</pages><co_aut>et al.</co_aut></literature><literature><id>7566</id><title>Compound heterozygous mutations in the TH gene in a Chinese family with autosomal-recessive dopa-responsive dystonia: A case report</title><author>Muranova AV,</author><journal>Medicine (Baltimore)</journal><year>2018</year><book /><volume>97</volume><number>44</number><pages>e12870</pages><co_aut>et al.</co_aut></literature><literature><id>3710</id><title>Tyrosine Hydroxylase Deficiency</title><author>Furukawa Y,</author><journal>GeneReviews&#174; [Internet]</journal><year>2017</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Kish S</co_aut></literature><literature><id>7567</id><title>An Indian Family with Tyrosine Hydroxylase Deficiency</title><author>Goswami JN,</author><journal>Indian Pediatr</journal><year>2017</year><book /><volume>54</volume><number>6</number><pages>499-501</pages><co_aut>Sankhyan N, Singhi PD</co_aut></literature><literature><id>7568</id><title>An unusual presentation of tyrosine hydroxylase deficiency</title><author>Katus LE,</author><journal>J Clin Mov Disord</journal><year>2017</year><book /><volume>4</volume><number>0</number><pages>18</pages><co_aut>Frucht SJ</co_aut></literature><literature><id>1967</id><title>Long-term course of L-dopa-responsive dystonia caused by tyrosine hydroxylase deficiency</title><author>Schiller A</author><journal>Neurology</journal><year>2004</year><book /><volume>63</volume><number>8</number><pages>1524-1526</pages><co_aut>et al.</co_aut></literature><literature><id>1969</id><title>L-dopa-responsive infantile hypokinetic rigid parkinsonism due to tyrosine hydroxylase deficiency</title><author>de Rijk-Van Andel JF</author><journal>Neurology</journal><year>2000</year><book /><volume>55</volume><number>12</number><pages>1926-1928</pages><co_aut>et al.</co_aut></literature><literature><id>1970</id><title>Four novel mutations in the tyrosine hydroxylase gene in patients with infantile parkinsonism</title><author>Swaans RJ</author><journal>Ann Hum Genet</journal><year>2000</year><book /><volume>64</volume><number>0</number><pages>25-31</pages><co_aut>et al.</co_aut></literature><literature><id>969</id><title>Biochemical hallmarks of tyrosine hydroxylase deficiency</title><author>Brautigam C</author><journal>Clin Chem</journal><year>1998</year><book /><volume>44</volume><number>9</number><pages>1897-1904</pages><co_aut>et al.</co_aut></literature><literature><id>970</id><title>A point mutation in the tyrosine hydroxylase gene associated with Segawas syndrome</title><author>Ludecke B</author><journal>Hum Genet</journal><year>1995</year><book /><volume>95</volume><number>0</number><pages>123-125</pages><co_aut>Dworniczak B, Bartholome K</co_aut></literature></Literatures></Disease>